Meeraam Acids Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.28 M
as on 16-11-2024
- Company Age 26 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 8.00 M
as on 16-11-2024
- Revenue 27.25%
(FY 2023)
- Profit 40.54%
(FY 2023)
- Ebitda 44.22%
(FY 2023)
- Net Worth 76.58%
(FY 2023)
- Total Assets 45.22%
(FY 2023)
About Meeraam Acids
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.28 M.
The company has closed loans amounting to ₹8.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Balasubramanian Ram, Chakkalakkal Lonappan, Sriram Rajalakshmi, and One other member serve as directors at the Company.
- CIN/LLPIN
U24116TZ1998PTC008514
- Company No.
008514
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Jul 1998
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Coimbatore
Industry
Company Details
- Location
Coimbatore, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Meeraam Acids?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balasubramanian Ram  | Director | 27-Jul-1998 | Current |
| Chakkalakkal Lonappan | Director | 19-Jun-2013 | Current |
| Sriram Rajalakshmi | Director | 22-Aug-2014 | Current |
| Sabarish Sriram | Director | Current |
Financial Performance of Meeraam Acids.
Meeraam Acids Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.25% increase. The company also saw a substantial improvement in profitability, with a 40.54% increase in profit. The company's net worth Soared by an impressive increase of 76.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Meeraam Acids?
In 2022, Meeraam Acids had a promoter holding of 99.64% and a public holding of 0.36%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 11 Dec 2013 | ₹2.00 M | Satisfied |
Hdfc Bank Limited Creation Date: 04 Mar 2010 | ₹1.50 M | Satisfied |
Hdfc Bank Limited Creation Date: 30 Jan 2010 | ₹3.20 M | Satisfied |
How Many Employees Work at Meeraam Acids?
Meeraam Acids has a workforce of 25 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meeraam Acids, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meeraam Acids's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
